David Stadnyk, company president and CEO, commented, “We are excited to be able to enter into an agreement to purchase a business that is established and has a realistic chance of acquiring a major MMPR commercial license from Health Canada.” Read more at http://www.stockhouse.com/news/natural-resources/2014/03/25/supreme-pharmaceuticals-(v-sl)-updates-conditional#gm1JBC21VuvA1q6y.99